GlucaGen

Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery

Beta-cell Response to Incretin Hormones in Cystic Fibrosis

Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)

Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)

Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome

GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance

Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes

Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus

Genetics of the Acute Response to Oral Semaglutide

Splanchnic Venous Capacitance in Postural Tachycardia Syndrome

Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes

Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes

Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes Mellitus

A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs

Effects of GH and Lirglutide on AgRP

Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease

The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients

GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH

Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment

Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)

Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.

GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac Surgery

Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery

Fibrosis Lessens After Metabolic Surgery

Insulin and Insulin Pulses During Fasting

The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy

Tirzepatide Weight Loss for MRD+ Early Breast Cancer

The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease

GLP-1R Agonist Treatment for Opioid Use Disorder

Glucagon-Like Peptide-1 Receptor Agonist in ADPKD

Graded Insulin Suppression Test P&F

GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 Diabetes

Development of a Non-invasive Method for Quantifying Cerebral Glucose Metabolism for Studying the Effect of Glucagon in Humans

iGlarLixi CGM Study in Chinese T2D Individuals After OADs

Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes

Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease

MAINTAIN (Mucosal AblatIoN Therapy After INcretins)

Liraglutide Treatment in Obese Infertile PCOS Women

Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study

Longitudinal Study of the GLUcagon REsponse to Hypoglycemia in Children and Adolescents With New-onset Type 1 DIAbetes

Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients

Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults

Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes

Effect of Fasting Recommendations Among Patients Using GLP-1 Receptor Agonists

Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

Food (Poly)Phenol Metabotypes and Beta-cell Mass and Function.

A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type 1 Diabetes

Tirzepatide in PWS, HO and GNSO

A Study of BGM0504 in Participants With Obesity

Effect of Tirzepatide on Markers of MASLD in Patients With Obesity

Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease

POTS-FLOW: Interplay Between Gut Hormones and Autonomic Postprandial Blood Flow Regulation in Patients With POTS

Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY)

Tirzepatide in MetALD

Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease

Rebalancing the Fat Content of the Heart and Muscles

Tirzepatide in Obesity-Driven Endometrial Cancer

Healthy Living BEYOND Weight Study

Effects of GLP-1 Formula on GLP-1 and Glucose Regulation

Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors

Tirzepatide Use in People With Obesity and Type 1 Diabetes

A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2)

A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia

Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial

Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity

Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS)

Tirzepatide in Idiopathic Intracranial Hypertension Trial

Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes

Phase I Study of XTL6001 Injection in Healthy and Obese Subjects

Effects of Dihydroberberine (DHB) on GLP-1, Glycemic Control, Appetite, and Mood in Adults With Pre-Diabetes

The Role of Glucagon in Glucose Metabolism in Humans With and Without Bariatric Surgery

Tirzepatide to Slow Biological Aging

Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)

Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity

A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity

Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control

A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)

Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With Obesity

Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD

Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes

A Clincial Study Testing Tirzepatide on Reproductive Function and Metabolic Health in Women With PCOS Who Are Overweight or Obese

A Clinical Trial Evaluating TQF3250 Capsules in Healthy Adult Subjects

Bariatric Surgery Combined With GLP-1 Receptor Agonists Study

A Trial Within Cohort Feasibility Study Design Comparing Standard of Care Versus Weight Loss (Achieved Through Tirzepatide) for Obesity-related Hypertension in Young Adults

Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and Reinitiation

Insulin-Mediated Glucose Uptake and Organ Perfusion Assessed by Total-Body PET During GIP and GLP-1 Infusion

Tirzepatide (Spartina) in Obese Kidney Transplant Recipients

The Postprandial Hypo-Avoid Study

Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis

Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight

Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1)

Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis

Efficacy and Safety of HDM1005 Compared to Tirzepatide in Obese Adults Without Diabetes

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol Secretion

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.

Multi-Site Trial of Tirzepatide for Smoking Cessation

A Trial of Oral VRB-103 Alone or in Combination With Oral Ecnoglutide (VRB-101) in Participants With Obesity or Overweight

GLP-1 Therapy After Bariatric Surgery in Chinese Patients With Obesity

Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists.

Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists

Gestational Response, Outcomes, and Weight After GLP-1 Use

A Clinical Trial Evaluating TQF3250 Capsules in Patients With Type 2 Diabetes Mellitus and Overweight/Obesity

Cardiovascular-kidney-metabolic (CKM)-Guided Therapy for Patients After Acute Coronary Syndrome

Evaluation of Anhedonia and Emotional Eating in Individuals Using GLP-1 Receptor Agonists

Diagnosis and Treatment of Pheochromocytoma

NNC 90-1170 Mechanism of Action: A Double-Blind, Randomized, Single-Center, Placebo-Controlled, Crossover Study to Examine Beta-Cell Responsiveness to Graded Glucose Infusion in Subjects With Type 2 Diabetes

Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials

Intravenous-Morphine and Glucagon-Usage Enhanced MR Cholangiography

Plasma Determination of Glucagon-like Peptide 2 as a Predictor of Recovery in Adults With Acute Intestinal Failure

The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men

The Study of HIV Protease Inhibitors and Their Effects on Glucose Metabolism

The Importance of Glucagon-Like Peptide-2 (GLP-2)in Mesenteric Bloodflow in Humans

To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1c

A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Very Low Dose-Glucagon in Subjects With Type 1 Diabetes Mellitus

Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetes

Efficacy and Safety of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes

Effect of Liraglutide in Combination With Sulfonylurea (SU) on Blood Glucose Control in Subjects With Type 2 Diabetes

The Effect of Liraglutide on Body Weight in Obese Subjects Without Diabetes

Glucagon in the Treatment of Hypoglycemia in Newborn Infants of Diabetic Mothers

Glucagon Like Peptides Receptors Expression in the Stomach of Diabetes Type 2

Treatment of Type 2 Diabetes Mellitus by Duodenal Exclusion Associated With Omentectomy: Clinical and Hormonal Study

Effect of GLP-1 and GIP on Insulin Secretion in Type-1 Diabetes Mellitus

Near Normalisation of BG Improves the Potentiating Effect of GLP-1

Beta-Cell Function After Near-Normalisation of Blood Glucose

Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes

The Effect of Liraglutide on Endothelial Function in Subjects With Type 2 Diabetes Mellitus

Incretin Physiology and Beta-cell Function Before and After Weight-loss

Effect of LAF237 on Glucagon Secretion in Patients With Type 2 Diabetes and in Healthy Subjects

Influence of Glucagon Inhibition in Relation to the Anti-Diabetic Effect of Glucagon-Like Peptide-1 (GLP-1) in Patients With Type 2 Diabetes Mellitus

Effect of the Enteric Hormone Glucagon-Like Peptide (GLP-2) on the Intestinal Blood Flow in Patients With Short Bowel Syndrome

Effects of Glutamine on GLP-1 and Insulin Secretion in Man

The Effect of Surgically Induced Weight Loss on Endocrine Function, Cardiovascular Function and Body Composition

A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and Liraglutide

The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus

How Improvement in Control of Diabetes Influences the Production of a Hormone Produced in the Gut Which Improves the Release and Action of Insulin.

To Investigate the Blood Concentration of Liraglutide as Well as the Effects on Glucose and Insulin After 21 Days of Daily Subcutaneous Injections of Liraglutide or Placebo

Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance

Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone

The Efficacy of Glucagon Like Peptide (GLP) - 1(7-36) Amide for Glycemic Control in Critically Ill Patients

Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure

Randomized Trial of ERCP Then Laparoscopic Cholecystectomy vs. Laparoscopic Cholecystectomy Plus Laparoscopic Common Bile Duct Exploration in Patients With Likely Choledocholithiasis

Closed-loop Glucose Control for Automated Management of Type 1 Diabetes

To Evaluate the Response to Glucagon During Hypoglycemia

A Phase 1 Study to Evaluate the Safety and Tolerability of GSK1362885 in Healthy Normal Subjects

Characterization of the Incretinpathy in Type 2 Diabetes Initiated After Sixty Years Old

Treatment With Sitagliptin for Reactive Hypoglycemia Secondary to Dysinsulinism

The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes

Glucagon-Like Peptide-1 (GLP-1) Suppression of Alpha Cell Secretion in Type 2 Diabetes Mellitus (T2DM)

Characterization of Beta Cell Failure

GLP 1 for Intraoperative Glycemic Control

A Pilot Study to Evaluate the Glucagon-Like Peptide 1 Response to the Challenge of Mixed Meals in Chinese Subjects

Effect of Exendin-(9-39) on Fasting Adaptation and Protein Sensitivity

Endothelial and Metabolic Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Circulation in Patients With Type 2 Diabetes Mellitus

Glucagon Modulation of Ghrelin Secretion

Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients

Effect of GLP - 1 (7-36 Amide) on Myocardial Function Following Coronary Artery Bypass (CABG) Surgery

Predictive Parameters for Efficacy of Sitagliptin and Metformin Combination

A Trial to Assess the Effect of Liraglutide on Gastric Emptying in Healthy Obese Volunteers

GLP-1 - Regulatory Mechanism of Postprandial Glycemia

Safety and Tolerability of NN9068 in Healthy Male Volunteers

Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes

Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes

Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes

Effects of ROSE-010 on GI Transit in Constipation Predominant Irritable Bowel Syndrome (C-IBS) Patients

Efficacy Of Autologous Bone Marrow Derived Stem Cell Transplantation In Patients With Type 2 Diabetes Mellitus-2

GIP and GLP-1 on Gastric Emptying, Appetite and Insulin-glucose

Sweet Taste Receptors and the Secretion of Glucagon-like Peptide-1 and Peptide YY

Integration of Continuous Glucose Monitoring Into a BiHormonal Closed-Loop Artificial Pancreas

Insulinotropic Effect of GIP and GLP-1 Before and After Reduced Glucose Tolerance

Effects of Lixisenatide Compared to Liraglutide on the Postprandial Plasma Glucose in Patients With Type 2 Diabetes

Intact Liver Innervation and Glucose and Glucagon-like Peptide-1 (GLP-1) Induced Insulin Secretion

Intact Vagal Innervation for and Glucagon-like Peptide-1 (GLP-1) Effects

Intact Vagal Innervation and Glucagon-like Peptide-1 (GLP-1) Effects

Effect of GLP-1 on Glucose Metabolism in CNS Assessed by PET

Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251)

Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell Transplantation

A Post Marketing Surveillance (PMS) Study of Liraglutide in Subjects With Type 2 Diabetes Mellitus in India

Observational Study on Efficacy and Safety of Liraglutide in Subjects With Type 2 Diabetes

Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)

Liraglutide Efficacy and Action in Non-Alcoholic Steatohepatitis

LIraglutide and Beta-cell RepAir (LIBRA) Study

Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes

Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes

Closed-loop Control of Glucose Levels in the Context of Exercise in Adults With Type-1 Diabetes

Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes

Gut Hormones After Roux-en-Y Gastric Bypass (RYGBP) Plus Gastric Fundus Resection

The Safety,Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus

Glucolipotoxicity and Type 2 Diabetes

Plasma Levels of Glucagon-like Peptide-2 and Dyspepsia in Patients With Extraintestinal Cancer During Chemotherapy

Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin

Liraglutide Treatment to Patients With Severe Renal Insufficiency

Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes

Evaluating the Safety and Effectiveness of Liraglutide in Subjects With Type 2 Diabetes

Peanuts Second Meal Glycemic Response

Role of Aprotinin in Glucagon Degradation, Measurement by Radioimmunoactive Method (RIA) I125

Pharmacokinetics Study of Dipeptidyl Peptidase 4 Inhibitor to Control Type 2 Diabetes Mellitus

GLP-1 Receptors in Normal Skin and Skin From Patients With Psoriasis

Diet Oil Induced Stimulation of GLP-1

The Effects of Physical Training and GLP-1 Receptor Agonist Liraglutide Treatment in Patients With Type 2 Diabetes

Effectiveness and Safety of Treatment of Insulin Glargine in Type 2 Diabetes Mellitus Following Glucagon-like Peptide-1 (GLP-1) Failure

A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus

Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2

Time Course of the Blood Pressure Lowering Effect of Liraglutide Therapy in Type 2 Diabetes

Adding Liraglutide to High Dose Insulin: Breaking the Cycle

Safety and Tolerability of Liraglutide in Healthy Male Volunteers

Safety and Tolerability of Liraglutide in Healthy Volunteers and Subjects With Type 2 Diabetes

Comparison of the Effect of Liraglutide in Young Versus Elderly Healthy Volunteers

The Effect of GLP-1 on the Inhibition of Glucagon Secretion

Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 Diabetes

Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 Diabetes

Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group

Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent

An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)

Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 Diabetes

Comparison of Liraglutide Injected at Three Different Injection Sites in Healthy Volunteers

Bioequivalence of Two Liraglutide Formulations in Healthy Volunteers

Comparison of Two Liraglutide Formulations in Healthy Subjects

Metabolism and Excretion of Liraglutide in Healthy Male Volunteers

Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both Medications

Comparison of Closed-loop Operation After Morning Meal With and Without Carbohydrate Counting

Effects of DPP-4 Inhibition on Triglycerides

Liraglutide Use in Prader-Willi Syndrome

Liraglutide Effects on Memory in Healthy Subjects

Artificial Pancreas Control System in an Inpatient Setting

Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea

A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus

DIabetes REsearCh on Patient sTratification (DIRECT): GLP-1R Agonists

The Importance of GLP-1 in Post RYGB Improvement in Glycaemic Control Type 2 Diabetic Subjects

A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus

GLP-1 Analogue Treatment in Uncontrolled Type 1 Diabetic Patients

A Long-term Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 Diabetes

Resveratrol-Leucine Metabolite Synergy in Pre-diabetes

Pharmacodynamic Effects of Lixisenatide Compared to Liraglutide in Patients With Type 2 Diabetes Not Adequately Controlled With Insulin Glargine With or Without Metformin

Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding

Impact of Liraglutide on Sensory Perception, Sensory Specific Satiety, Liking and Wanting in Type 2 Diabetic Patients

The Effect of LY2409021 on Blood Sugar Levels When Glucagon Levels Are Increased in Healthy Male Participants

Modulation of Human Myocardial Metabolism by GLP-1 Dose Response

Exercise, Glucose Kinetics, and the Incretin Effect

Safety and Tolerability of Liraglutide in Japanese Subjects With Type 2 Diabetes

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Healthy Japanese Volunteers

Safety and Tolerability of Liraglutide in Healthy Japanese Volunteers

Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment

A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes

Study of LY2409021 in Participants With Type 1 Diabetes

Treatment With Sitagliptin in Non-obese Japanese Patients With Type 2 Diabetes Mellitus

The Impact of Gall Bladder Emptying and Bile Acids on the Human GLP-1-secretion

Comparison of Bowel Ultrasound & MR Enterography in the Follow-up of Previously Diagnosed Pediatric Small Bowel Crohn Disease

Effect of Glucagon on Uterine Contractility at the Time of Embryo Transfer in in Vitro Fertilization

The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy

Testing State of the Art Remote Glucose Monitoring at Diabetes Camp

Pharmacokinetic Comparison of Intradermal Versus Sub-cutaneous Insulin and Glucagon Delivery in Type 1 Diabetes

Vasodilatory and Metabolic Effects of Glucagon-like Peptide-1 in Periphery Circulation in Patients With and Without Type 2 Diabetes Mellitus

Liraglutide in Type 1 Diabetes

Liraglutide in the Treatment of Type 1 Diabetes Mellitus

Influence of Appetite Related Hormones in Binge Eating Behaviour Among the Overweight and Obese

GIP and GLP-1 in Type 1 Diabetes

Immune Biomarkers of Residual Beta-cell Mass in Type 1 Diabetes

Hyperglycemia and the Extra-pancreatic Effect of Incretins

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 24 Hours in Adults and Adolescents With Type 1 Diabetes

Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting

Effect of GLP-1 on Postprandial Lipid Metabolism

Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients

Outpatient Automated Blood Glucose Control With a Bi-hormonal Bionic Endocrine Pancreas

A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes Mellitus

RISE Adult Medication Study

Rapid Versus Slow Ingestion of Mixed Meal: Influence on Islet and Incretin Hormone Secretion in Healthy Volunteers

Incretin Effect on the Immunological Phenotype

52 Week Trial of Liraglutide in Type 1 Diabetes

Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function

Incretin Regulation of Insulin Secretion in Monogenic Diabetes

Mixed Meal Test in Type 1 Diabetes: Optimization of Artificial Pancreas-Pilot Study

Exenatide on GI Motor Function and Permeability in Short Bowel Syndrome

A Pilot Study of the Effects on Sleep Disordered Breathing (SDB) When Using the Drug Liraglutide for 4 Weeks

The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes

A Study to Evaluate the Effect of Ranolazine on Postprandial Glucagon in Subjects With Type 2 Diabetes.

Effect of Liraglutide on Automated Closed-loop Glucose Control in Type 1 Diabetes

GLP-1 and Hypoglycemia

Liraglutide in Newly Onset Type 1 Diabetes.

Retrospective Collection of Effectiveness and Safety Data From Patients Treated With Liraglutide or DPP-4 Inhibitor in Primary Care in Europe

Polycystic Ovary Syndrome and Liraglutide

Closed-loop Control of Overnight Glucose Levels in Adults and Adolescents With Type 1 Diabetes

Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin

Polycystic Ovary Syndrome and Liraglutide as Add-on Therapy on Metformin

Trial to Compare the Relative Pharmacodynamic Properties of Different Glucagon Dosages

Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 Diabetes

Liraglutide Hospital Discharge Trial

Closed-loop Control of Glucose Levels (Artificial Pancreas) During Exercise in Adults With Type 1 Diabetes

Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes.

Investigating Brown Adipose Tissue Activation in Humans

Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2D

Effect of Meal Number, Frequency, and Form on Satiety and Metabolism After Weight Loss Surgery

The Role of Cholinergic Signaling for Mediating the Effects of GIP and/or Xenin-25 on Insulin Secretion

Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon Like Peptide 2

Evaluate the Immunogenicity of a Novel Glucagon Formulation

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 60 Hours in Adults With Type 1 Diabetes

The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study

Efficacy and Safety of Liraglutide Versus Lixisenatide as add-on to Metformin in Subjects With Type 2 Diabetes

Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in Adults

Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes

Efficacy Study of Glucagonlike Peptide-1 to Treat Reperfusion Injury

Mixed Meal Test in Type 1 Diabetes on Insulin Pump Therapy: Optimization of Artificial Pancreas

Endogenous Glucoseproduction in Patients With Type 2 Diabetes Mellitus During Oral Glucose and iv. Glucose Infusion

A Study of MK-0893 on Glucagon-Induced Glycemic Excursion in Healthy Male Participants Following Intravenous Administration of Glucagon, Sandostatine® and Insulin (MK-0893-002)

Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis

Equivalence of A Stable Liquid Glucagon Formulation With Freshly Reconstituted Lyophilized Glucagon

Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus

Location of GLP-1 Release

Roux-en-Y Gastric Bypass for BMI 27-32 Type 2 Diabetes Versus Best Medical Treatment

Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)

A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)

LIPT - Liraglutide in Polycystic Ovary Syndrome

Effect of LAPS-Exendin on Body Weight in Obese Population

Safety and Efficacy Study of Mini-Dose Glucagon (G-Pen Mini) in Patients With Type 1 Diabetes

GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations

Bioequivalence of Fresenius Kabi USA, LLC Glucagon for SC Injection Compared to Glucagon for Injection (Bedford Laboratories)

Liraglutide as add-on to Insulin in Type 1 Diabetes

The Summer Camp Study 2: Blood Glucose Control With a Bi-Hormonal Endocrine Pancreas

Addition of Liraglutide to Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections

GLP-1 Loading During Elective Percutaneous Coronary Intervention

Cardioprotective Effects of GLP-1 and Their Mechanisms

Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects

The Differential Effects of Diabetes Therapy on Inflammation

Closed-Loop Glucagon Administration For Hypoglycemia Treatment

Closed-loop Control of Overnight Glucose Levels (Artificial Pancreas) in Children With Type 1 Diabetes in a Diabetes Camp

Correlation Between Plasma- and Endothelial DPP-4 Activity

A Study of Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With Metformin

Investigating Bioequivalence Between Single-dose Liraglutide Administered Subcutaneously With Two Different Pen-injectors

SEGATROM: Sensory and Gastrointestinal Impact of Taste Receptor Variants on Human Metabolism and Nutrition

Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus

Albiglutide Versus Placebo Added-on to Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes Mellitus

Treatment of Low Blood Sugar With Glucagon Among Patients With Type 1 Diabetes

Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects

Effects of Glucagon Administration on Energy Expenditure

The Effect of the Incretin Hormones on the Endocrine Pancreatic Function During Hyperglycemia in End-stage Renal Disease

Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.

Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Daily Practice

Effect of LIXIsenatide on the Renal System

Is Glucagon-like Peptide-1 Insufficiency a Residual Risk in Coronary Artery Disease?

Closed-loop Control of Overnight Glucose Levels (Artificial Pancreas) in Type 1 Diabètes Adults With Hypoglycemia Unawareness and Documented Nocturnal Hypoglycemia

Effect of Cycloset on Glycemic Control When Added to Glucagon-like Peptide 1 (GLP-1) Analogue Therapy

GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administration

Involvement of Steatosis-induced Glucagon Resistance in Hyperglucagonaemia

Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes

The Lira Pump Trial

Postprandial Blood Glucose Control and Gastric Emptying in Type 1 Diabetes: Pathogenetic Factors and Therapeutic Options

Single Ascending Doses of ZP4207 Administered in HV and in T1D to Evaluate Safety, Tolerability PKs and PDs of ZP4207 Compared to a Comparator

Characterizing the Incretin Effect of Amino Acids and Defining GLP-1 Role on Skeletal Muscle

The Effect of Different Macronutrients on Gastrointestinal Hormone Secretion After Gastric Bypass Operation

DiaCon Dual-Hormone Closed-Loop Glucose Control

Food Intake and Gut Hormones in Patients Who Have Undergone Upper Gastrointestinal Surgery for Cancer

Longitudinal Assessment of Gut Hormone Secretion Following Upper Gastrointestinal Surgery for Cancer

Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents

The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans

COMBinAtion Therapy in Myocardial Infarction: The COMBAT-MI Trial

Closed-loop Control of Postprandial Glucose Levels in Adults With Type 1 Diabetes

Pretreatment of Patients Expecting Bariatric Surgery With the GLP-1 Analogon Liraglutid

G-Pen™ for Hypoglycemia Rescue in T1D Patients

Research of Intensive Lifestyle Intervention for PCOS Patients With IGT

Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes

The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function

Incretin-based Drugs and Acute Pancreatitis

The PIT-TBI Pilot Study

Improving Beta Cell Function in Mexican American Women With Prediabetes

A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus.

Effects of Glucagon Like Peptide-1 on No-reflow

Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes

Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome

Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin Treatment

Tofogliflozin GLP-1 Analogue Combination Trial

Antiproteinuric Effects of Liraglutide Treatment

Incretin Action in Physiology and Diabetes

Glucagon Efficiency After High and Low Carbohydrate Diet

A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus.

Preoperative Condition in Giant Obese Patients

A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Doses of SAR438544 in Comparison to Placebo and Glucagon in Healthy Subjects and Type 1 Diabetes Mellitus Patients

Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation

A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SAR438544 in Comparison to Glucagon in Type 1 Diabetes Mellitus Patients Under Induced Hypoglycemia

EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)

Effects of Beta-glucan on Energy Intake and Satiety

Study of the Safety and Tolerability of Switching to ITCA 650 in Patients With Type 2 Diabetes Receiving Liraglutide

Pilot Study of the Effect of Liraglutide on Weight Loss and Gastric Functions in Obesity

Effects of GLP-1 on Chronic Heart Failure

Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes Patients

Safety and Efficacy of G-Pen Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics

Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients of South Asian Descent

The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes

Assessment of Insulin Sensitivity and β Cell Function by Clamps Studies

Can Postprandial Reactive Hypoglycaemia be Reduced in Patients After Roux-en-Y Gastric Bypass With a Low Carbohydrate Diet?

The Reduced Insulinotropic Effect of a Continuous Infusion Relative to a Bolus Injection of GIP

GLP-1 and Hyperoxia for Organ Protection in Heart Surgery

The iLet Introduction Study: A Feasibility Study of the iLet, a Fully Integrated Bihormonal Bionic Pancreas

A Trial to Assess the Effects of Liraglutide on Gallbladder Emptying in Overweight and Obese Subjects.

Effect of Liraglutide on Fatty Liver Content and Lipoprotein Metabolism

GLP-1 Inhibits Prandial Antro-duodeno-jejunal Motility in Humans

Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Hypoglycemia in Post-Bariatric Surgery Patients

Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes

Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor Agonist

Assessment of Intranasal Glucagon on Endogenous Glucose Production

Glucagon Like Peptide-1 in Remote Ischemic Conditioning

Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus Subjects

A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM)

The Effect of Liraglutide Treatment on Postprandial Chylomicron and VLDL Kinetics, Liver Fat and de Novo Lipogenesis

Timely Detection of Treatment Emergent Serious and Non-serious Adverse Events for Saxenda® in Mexican Patients

Effects of Single Doses of Liraglutide and Dapagliflozin on Ketogenesis in Type 1 Diabetes

A Study of Glucagon Administered in Different Forms and Routes to Healthy Adults

The Effect of Acipimox on GLP (Glucagon-like Peptide)-1 Secretion

Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation - Part 2

A Study of Single or Repeated Doses of Glucagon in Participants With Diabetes

The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Non-stroke Volunteers

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 15 Weeks in Adolescents and Adults With Type 1 Diabetes

Sodium-glucose Co-transporter 2 (SGLT2) Inhibitor Risk of Below-Knee Lower Extremity Amputation: A Retrospective Cohort Study Using a Large Claims Database in the United States

Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy

Four Way Crossover Closed Loop With Exercise Detection

Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus

Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity

HbA1c Variability in Type II Diabetes

Carbohydrates and Gut Hormones After Gastric Bypass Surgery

Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM

Genetics of Response to Canagliflozin

GLP-1/Basal Insulin Combination Therapy

Liraglutide 3 mg for Knee Osteoarthritis

Incretin-based Therapy in Early Diagnosed Type 1 Diabetes

Low Dose Liraglutide and Metformin vs. High Dose Liraglutide Alone in Treatment of Obesity

Lifestyle Modification and Liraglutide

ZP4207(Dasiglucagon) Administered to T1D Patients to Assess the PK and PD Compared to Marketed Glucagon

Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat

Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance

CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism

GLP-1 Signaling in Truncally Vagotomized Subjects

Delineation of the Diabetogenic Role of Extrapancreatic Glucagon in Totally Pancreatectomised Patients Using Glucagon Receptor Antagonism

Safety and Efficacy of Liraglutide in Parkinson's Disease

Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal Insulin

Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting

LIRA-ADD2SGLT2i - Liraglutide Versus Placebo as add-on to SGLT2 Inhibitors.

The Monitoring Study

Feasibility Trial Testing the Bionic Pancreas With ZP4207

A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus

Clinical Outcomes of Exenatide Versus Basal Insulin

Endocrine and Neural Control of Eating in Women

Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes Mellitus

Safety and Efficacy of Umbilical Cord Blood Regulatory T Cells Plus Liraglutide on Autoimmune Diabetes

Saxenda in Obesity Services (STRIVE Study)

Clinical Efficacy and Safety of Using 3.0mg Liraglutide to Treat Weight Regain After Roux-en-Y Gastric Bypass Surgery

Characterization of Metabolic and Brain Effects of Rising Glucagon During an Oral Glucose Challenge

The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea

Glucose Response of G-Pen (Glucagon Injection) in Pediatric T1D Patients

Treatment Plan for an Individual Patient With Pasireotide for Hyperinsulinemic Hypoglycemia

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus

A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)

Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM)

Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 Diabetes

Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues

A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus

Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?

A Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes

Glucagon in MODY (Maturity Onset Diabetes of the Young)

Closed-Loop Glucagon Pump for Treatment of Post-Bariatric Hypoglycemia

Liraglutide Effects on Epicardial Fat Inflammatory Genes

Once Weekly GLP-1 in Persons With Spinal Cord Injury

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes

Plasma Glucagon-like Peptide-1 Levels and In-hospital Complications in ST-segment Elevation Myocardial Infarction

Can Exenatide Prevent Increase in EGP in Response to Dapagliflozin-induced Increase in Glucosuria

A Study of Nasal Glucagon in Participants With Type 1 Diabetes Mellitus

Reward Mechanisms in Obesity

The Effect of a Liraglutide on IVF in Obese PCOS

Comparative Effectiveness of Empagliflozin in the US

Liraglutide on Decreasing Parenteral Support in Short Bowel Patients (SLIPS)

Individualized Obesity Pharmacotherapy

A Study of Tirzepatide (LY3298176) in Healthy Participants

A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects

Comparing Efficacy and Safety of CinnaGen-liraglutide Versus Victoza® in Patients With Type II Diabetes

A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus

The Effects of Liraglutide on Sudomotor Function and Inflammation in Type 2 Diabetes

Glucose Absorption and Gut Hormone Secretion After Gastric Bypass

G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes

Glucagon-like Peptide-2 Mediated Secretion of Stored Enteral Lipids

First Research Study to Compare a Possible New Medicine NNC9204-1513 to the Medicine Glucagon, in Healthy People.

Effects of Exenatide on Motor Function and the Brain

Effects of Liraglutide in Chronic Obstructive Pulmonary Disease

Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS

A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function

A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants

A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease

Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging

The Effect of Liraglutide on Pancreatic Hormones and Its Size

Pilot Study of the Effect of Liraglutide 3.0 mg on Weight Loss and Gastric Functions in Obesity

Glucagon's Cardiovascular Effects With and Without Beta-blocker-induced Cardioinhibition

Weight Loss With Intensive Lifestyle Modifications Plus Bariatric Surgery Versus Liraglutide 3 mg

A Regulatory Post-marketing Surveillance (rPMS) Study to Evaluate the Safety and Effectiveness of Saxenda®(Liraglutide 3.0 mg) in Obese Patients and Overweight Patients With Obesity-related Comorbidities in Routine Clinical Practice in Korea.

Effects of Gut Peptides on Bone Remodeling

Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism.

Glucagon-like Peptide-1 Levels, Insulin Resistance and Insulin Sensitivity Index in Type 2 Diabetes Mellitus

Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients

The Use of Liraglutide in Brain Death

Effect of Glucagon-like Peptide 2 on Gallbladder Motility After a Meal in Young, Healthy Male Subjects

Effect of GIP After a Meal in Patients With Type 2 Diabetes

Effects of Liraglutide on the Cognitive Function in Patients With Type 2 Diabetes Mellitus

Effects of Dapagliflozin+Saxagliptin in Addition to Metformin v/s Saxagliptin or Dapagliflozin in Patients With DM2.

The Effects of Neprilysin on Glucagon-like Peptide-1

Effects of a Liquid Meal and Gut Hormones (GIP and GLP-2) on Bone Remodeling in Participants With Hypoparathyroidism.

The Role of Glucose-Dependent Insulinotropic Polypeptide in the Pathological Glucose Homeostasis Of Type 1 Diabetes

Multiple Ascending Dose Study of AMG 598 in Adults With Obesity

A Study Comparing User Experience of Different Delivery Devices for Glucagon

Glucagon Ready to Use (RTU) in Subjects With Hyperinsulinemic Hypoglycemia After Bariatric Surgery

A Two-Period Open-label Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism

The Influence of Nocturnal Food Intake in Eating Behavior of Night Workers

DIA_CENTRAL:T2D Treatment Pattern in Central Europe

NAFLD Among Patients With Type 2 Diabetes and CKD

Formulas for Diabetes With Sucromalt & Isomaltulose on Glycemic Index, Hormones & Subjective Appetite in Type 2 Diabetes

The Bihormonal iLet Bionic Pancreas Feasibility Study

Glucagon Ready-to-Use (RTU) for Prevention of Exercise-Induced Hypoglycemia During Aerobic Exercise in Adults With T1D

A Pathophysiological Study of the Postprandial Human Liver (PLS)

Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.

Effects of Oral Glucose and Teduglutide on Plasma Lipoproteins

A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes

NAFLD Among Patients With Chronic Kidney Disease and the Effect of Kidney Transplantation

3mg Liraglutide for Overweight or Obesity

A Research Study Looking at How Victoza® Works in People With Type 2 Diabetes in Iran, Followed in Local Clinical Routine

Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS

Metabolic Pathways of GRA in Patients With Type 1 Diabetes

A Study of Tirzepatide in Participants With Impaired Liver Function

Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients With Type 2 Diabetes Mellitus

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone

Glucagon-like Peptide 2 - a Glucose Dependent Glucagonotropic Hormone?

Human Solute Carrier Family 5 Member 2 (SLC5A2) Deficiency and the Glucagon-Incretin Axis

Effectiveness of Exenatide Plus Dapagliflozin on 24 Hour Glucose Variability Measured by CGM. A Proof of Concept.

Effects of Benaglutide on Weight and Gut Microbiota in Obese Patients

A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes

Phenotypic and Genotypic Characterization of New-onset Type I Diabetes

Comparison of Probiotics, Metformin & Their Combination Therapy in the Treatment of PCOS

Simplification of Complex Insulin Regimens With Preserving Good Glycemic Control in Type 2 Diabetes

Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients

Cardiovascular Outcomes and HbA1c Among Patients With Type 2 Diabetes Newly Initiating GLP1RAs vs Basal Insulin

A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin

Effect of Liraglutide on Microbiome in Obesity

A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus

A Study of Tirzepatide at Different Injection Sites in Participants With Different Body Sizes

Dual-hormone Closed-loop Glucose Control in Type 1 Diabetes

Effect of Liraglutide on the Metabolic Profile in Patients With Type 2 Diabetes and Cardiovascular Disease

Involvement of Dipeptidyl Peptidase-4 and Sodium-glucose Co-transporter-2 in Extrapancreatic Glucagon Secretion

Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or Obesity

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo)

Clinical Study on the Improvement of Diabetic Neuropathic Pain by Liraglutide

A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)

Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism

A Study of the Effect of Tirzepatide on How the Body Handles Birth Control Pills in Healthy Female Participants

A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight

Co-infusion of Neurotensin and GLP-1 Effects on Appetite and Food Intake.

Effect of Liraglutide vs CPAP on Cardiometabolic Outcomes in Obstructive Sleep Apnea

Micro Glucagon During Exercise in Type 1 Diabetes

Use of a GLP-1R Agonist to Treat Opioid Use Disorder

Investigation of Vasodilation and Intensity of Headache Triggered by Glucagon Like Peptide-1 in Humans

A Study of Tirzepatide in Chinese Participants With Type 2 Diabetes Mellitus